Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
ClinicalTrials.gov study NCT05800210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL
ClinicalTrials.gov study NCT00385125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04833114. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05923879. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL
ClinicalTrials.gov study NCT00077961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms
ClinicalTrials.gov study NCT07234045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase I
ClinicalTrials.gov study NCT06835530. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
ClinicalTrials.gov study NCT03352765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07124936. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Inf
ClinicalTrials.gov study NCT06947499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells
ClinicalTrials.gov study NCT03755297. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
ClinicalTrials.gov study NCT06970496. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
ClinicalTrials.gov study NCT05683717. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04812691. IPD Sharing: NO. Countries: 1. Publications: 0.
Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas
ClinicalTrials.gov study NCT01786018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic F
ClinicalTrials.gov study NCT05451810. IPD Sharing: YES. Countries: 2. Publications: 0.
Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06876688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
ClinicalTrials.gov study NCT01604031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02931201. IPD Sharing: NO. Countries: 1. Publications: 0.
CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma
ClinicalTrials.gov study NCT04578600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.